$-0.01 EPS Expected for Neovasc Inc. (NVCN); Tremblant Capital Group Cut Its Tim Participacoes S A (TSU) Stake

April 22, 2018 - By Marie Mckinney

Neovasc Inc. (NASDAQ:NVCN) Logo

Tremblant Capital Group decreased Tim Participacoes S A (TSU) stake by 13.17% reported in 2017Q4 SEC filing. Tremblant Capital Group sold 608,023 shares as Tim Participacoes S A (TSU)’s stock rose 12.28%. The Tremblant Capital Group holds 4.01M shares with $77.44M value, down from 4.62M last quarter. Tim Participacoes S A now has $11.52B valuation. The stock decreased 0.39% or $0.09 during the last trading session, reaching $22.78. About 541,949 shares traded. TIM Participações S.A. (NYSE:TSU) has risen 31.98% since April 22, 2017 and is uptrending. It has outperformed by 20.43% the S&P500.

Analysts expect Neovasc Inc. (NASDAQ:NVCN) to report $-0.01 EPS on May, 9.They anticipate $0.09 EPS change or 90.00% from last quarter’s $-0.1 EPS. After having $-0.02 EPS previously, Neovasc Inc.’s analysts see -50.00% EPS growth. The stock increased 1.88% or $0.001 during the last trading session, reaching $0.049. About 47.32M shares traded. Neovasc Inc. (NASDAQ:NVCN) has declined 92.17% since April 22, 2017 and is downtrending. It has underperformed by 103.72% the S&P500.

Among 4 analysts covering Neovasc (NASDAQ:NVCN), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Neovasc had 9 analyst reports since August 12, 2015 according to SRatingsIntel. As per Thursday, December 10, the company rating was initiated by Ladenburg Thalmann. The stock of Neovasc Inc. (NASDAQ:NVCN) earned “Outperform” rating by Leerink Swann on Thursday, March 29. Canaccord Genuity maintained the stock with “Buy” rating in Tuesday, August 25 report. The firm earned “Neutral” rating on Friday, May 20 by Ladenburg Thalmann. The rating was initiated by JMP Securities with “Market Outperform” on Wednesday, October 7. On Wednesday, August 26 the stock rating was downgraded by Zacks to “Hold”. The company was downgraded on Wednesday, August 12 by Zacks. Canaccord Genuity maintained Neovasc Inc. (NASDAQ:NVCN) on Thursday, March 29 with “Buy” rating.

Neovasc Inc., a specialty medical device company, develops, makes, and markets cardiovascular devices worldwide. The company has market cap of $22.08 million. The Company’s products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. It currently has negative earnings. The firm also provides Peripatch biological tissue products that are used as components in third-party medical products, such as transcatheter heart valves for industry partners and other customers.

Among 7 analysts covering TIM Participacoes (NYSE:TSU), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. TIM Participacoes had 29 analyst reports since August 5, 2015 according to SRatingsIntel. The firm has “Sell” rating given on Friday, December 18 by Goldman Sachs. Barclays Capital maintained the shares of TSU in report on Thursday, July 27 with “Overweight” rating. RBC Capital Markets maintained TIM Participações S.A. (NYSE:TSU) rating on Monday, July 31. RBC Capital Markets has “Hold” rating and $15.5000 target. JP Morgan downgraded TIM Participações S.A. (NYSE:TSU) on Wednesday, August 5 to “Neutral” rating. The firm has “Buy” rating given on Tuesday, July 26 by Bank of America. RBC Capital Markets maintained the shares of TSU in report on Friday, March 9 with “Hold” rating. The firm has “Neutral” rating given on Friday, August 21 by Bank of America. The rating was upgraded by Morgan Stanley to “Overweight” on Monday, January 23. On Thursday, November 30 the stock rating was maintained by RBC Capital Markets with “Hold”. The stock of TIM Participações S.A. (NYSE:TSU) has “Hold” rating given on Monday, February 5 by Scotia Capital.

TIM Participações S.A. (NYSE:TSU) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts